RxDoctor Payments Data

Kristalyn Gallagher, DO

Surgical Oncology · Chapel Hill, NCNPI 1114156130

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (29.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Elucent Medical at 44.7% of the total. Among surgical oncology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,858in general payments, 2019–2025

Across 119 payments — averaging $452.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elucent Medical$24K
  • Endomagnetics Ltd$24K
  • Leica Microsystems Inc.$2K
  • KUB Technologies Inc.$2K
  • Hologic Sales And Service, LLC$772
  • Vector Surgical, LLC$300
  • plus $735 from 7 others
$2,265in research payments, 2019–2025

Across 1 payment — averaging $2265.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endomagnetics Ltd$2K

What the payments were for

  • Consulting fees$15,20028%
  • Speaking & faculty fees$12,02422%
  • Travel & lodging$15,96630%
  • Food & beverage$10,31619%
  • Entertainment$3521%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Elucent Medical19$24,069
Endomagnetics Ltd73$23,805
Leica Microsystems Inc.2$2,328
KUB Technologies Inc.5$1,848
Hologic Sales And Service, LLC10$772
Vector Surgical, LLC1$300
Johnson & Johnson2$220
GE HealthCare1$128
Merit Medical Systems Inc1$120
Medtronic1$90
Baxter Healthcare1$86
Bioptics, Inc.2$76
Pharmacyclics LLC, An Abbvie Company1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,858 in reported general payments places this provider in the 95th percentile of 34 surgical oncology providers in North Carolina.

See all surgical oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$88,554
Medicare patients
109
Services billed
347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline21$606
Letrozole13$397
Tamoxifen Citrate15$217

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →